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Objective: The aim of this study was to assess and compare the efficacy of PTA and surgery in the treatment of severe 
lower limb ischaemia. 
Design" Prospective 12-month study of 180 consecutive patients with severe chronic lower limb ischaemia. 
Methods: PTA was used as first line therapy whenever possible and appropriate. Surgical revascularisation, primary 
amputation and conservative therapy were used in the remaining patients. Patient survival and limb salvage were derived 
using life table analysis. 
Results: Revascularisation was attempted in 135 (75%) patients, with PTA in 82 (46%), surgery in 49 (27%) and a 
combination of both in four (2%). Overall 12-month survival and limb salvage was 75% and 71%, respectively. Surgery 
and PTA had significantly higher survival rates (91% and 78%) than primary amputation or conservative therapy (57% 
and 52%) (p<O.O001 log rank test). Revascularisation with either surgery or PTA achieved the same limb salvage rate 
of 76%. 
Conclusion: A large proportion of patients with severe chronic lower limb ischaemia can be managed by PTA. This 
management strategy produces a clinically effective outcome at 1-year. 
Introduction 
Chronic severe lower limb ischaemia is a common 
problem facing the vascular surgeon with considerable 
implications for the organisation ofvascular services. 1'2 
Although it is generally accepted that revascularisation 
should be attempted wherever possible and ap- 
propriate, 2 the role of percutaneous transluminal n- 
gioplasty (PTA) and surgery in achieving this goal has 
recently been the source of controversy. 3 Doubts about 
the technical success rate and long-term patency of 
infrainguinal nd infrapopliteal PTA have been raised, 
leading to calls for randomised controlled trials. 3'4 
Although such pleas are laudable they are arguably 
misplaced in this context, since the two available treat- 
ment options are not mutually exclusive. In order to 
achieve limb salvage PTA represents a "minimally 
invasive" first line of treatment that does not preclude 
subsequent surgery if required3 Providing PTA can 
be shown to be an effective therapy when used in this 
way, its use can be justified. 
In order to evaluate the efficacy of PTA for the 
treatment of severe limb ischaemia we undertook a
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CB2 2QQ, U.K. 
prospective 12-month observational study in our unit 
where the policy was to use PTA as first line therapy 
whenever possible. The purpose of the study was to 
determine the consequences of this treatment s rategy 
and establish whether this policy was justified. 
Patients and Methods 
All patients presenting during 1994 to our vascular 
unit with chronic severe leg ischaemia (rest pain, 
ulceration or gangrene present for greater than 2 
weeks) were prospectively entered into the study. 
The intention was to recruit "all comers", including 
outlying referrals on medical, rehabilitation and der- 
matological wards. The details of the original 188 
patients and their initial management have previously 
been reported. 6 In appropriate cases, duplex scanning 
or angiography was used to characterise the arterial 
lesions and a joint decision taken between the vascular 
surgeon and radiologist regarding the suitability of 
PTA as the first line of therapy. 
Intervention with PTA was considered whenever 
possible, including iliac occlusions, flush superficial 
femoral artery occlusions, and crural vessel esions. 
Very extensive multi-level disease and heavy cal- 
cification were the only relative contraindications to 
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PTA where reconstructive surgery was used as the 
first option. Patients who were wheelchair bound, 
had extensive necrosis or joint contractures preventing 
walking were treated with primary major amputation. 
Conservative therapies were adopted for the re- 
maining patients, including sympathectomy, anal- 
gesia, antibiotics, ulcer dressings and subsequent 
rehabilitation. Spinal cord stimulation and phar- 
macological therapy (i.e. iloprost) were not in routine 
use in our unit during this study. 
A minimum of 12 months follow-up was undertaken 
for each patient in order to determine limb salvage 
and survival. Patients were reviewed in the vascular 
clinic or vascular studies unit (VSU). The clinical status 
of the leg was recorded and for those attending VSU, 
usually for graft surveillance, a colour duplex graft 
scan performed. In those patients discharged from 
follow up before 12 months where the outcome was 
unknown (n =21) the general practitioner was sent a 
brief questionnaire including a request o contact he 
patient directly if necessary. Four patients were con- 
tacted directly by phone. Complete 12-month follow- 
up data was obtained for 180 patients (187 legs), eight 
of the original cohort moved out of the area or were 
distant ertiary referrals and could not be traced. The 
following event details were recorded; death, with 
particular note of deaths directly due to limb isch- 
aemia; limb salvage; on-going limb ischaemia t 12 
months or at time of death; requirement of further 
vascular interventions. The principal study end points 
were patient survival and limb salvage rates. In 11 
cases PTA failed within 30 days and surgery was 
used to achieve limb salvage. These were classified as 
primary PTA procedural failures in the analysis. 
Data analysis 
Data were entered onto a computer software database 
(Statistical Package for the Social Sciences for Windows 
release 6, Chicago, Illinois, U.S.A.). The Chi-squared 
test with a continuity correction was used for com- 
parison of proportions. Survival and limb salvage were 
calculated using life table analysis with the log rank 
test to compare survival probabilities. 
The details of these procedures are shown in Table 1. 
Subintimal PTA 7 was used to recanalise 42 of the 51 
occlusions in the PTA group. Primary amputation 
was carried out in 14 (8%) patients and conservative 
therapy in 31 (17%). 
Survival 
The overall 12-month patient survival was 75%. The 
survival rate for each treatment group is shown in Fig. 
1. Patients undergoing revascularisation with either 
surgery or PTA had significantly higher 12-month 
survival rates (91% and 78%) than those treated with 
primary amputation or conservatively (57% and 52%) 
(p<0.0001 log rank test). A high proportion (66%) of 
the deaths in the conservatively treated group resulted 
from on-going limb ischaemia. 
Limb salvage 
The overall 12-month limb salvage rate was 71%. The 
limb salvage rate for patients treated with either PTA 
or surgery was 76% (Fig. 2). Although many patients 
in the conservatively treated group did not actually 
come to amputation they did have on-going limb 
ischaemia t the time of death or at 12 months. Only 
10 (32%) had resolution of their rest pain or tissue 
necrosis. Overall, at the end of the study, 89 patients 
(49% of the total) were alive with a useful, non- 
ischaemic, leg. 
Further vascular procedures 
Seven surgical revascularisations were required uring 
the first year following failed PTA, and five emergency 
procedures were performed for PTA complicated by 
embolism/thrombosis. All of these were successful 
except for one case where extensive distal athero- 
embolisation during PTA was not salvageable by sur- 
gery. Two failed PTA procedures were managed 
successfully by a repeat procedure. Fifteen grafts with 
stenoses, inflow and run-off disease were treated by 
PTA to maintain assisted primary patency. Nine failed 
or failing grafts were revised or replaced surgically. 
Results 
Revascularisation was attempted initially in 135 (75%) 
patients with PTA in 82 (46%) and surgery in 53 (29%). 
Discussion 
The overall 75% 1-year survival rate from this study 
is in keeping with the findings of previous series 8'9 
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Tab le  1. Summary  o f  surg ica l  p rocedures  per fo rmed and  the  s i te  and  nature  o f  PTA  les ions .  
PTA procedure No. Surgical procedure No. 
Iliac occlusion 2 Femorocrural bypass graft 24 
Iliac stenosis 8 Femoropopliteal bypass graft 19 
Femoropopliteal occlusion 30 Aortic bifurcated graft 4 
Femoropopliteal stenoses 28 Femoral endarterectomy 2 
Crural occlusion 19 Iliopopliteal bypass graft 4 
Crural stenoses 18 Iliofem bypass graft 3 
Thrombectomy 3 
Extra-anatomic bypass graft 4 
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Fig. 1. Life table showing cumulative proportion surviving for surgery ( i - -n ) ;  PTA (A . . . .  &); amputation ( , - - - -~) ;  conservative 
therapy (O- - - - -O) .  Log rank statistic for all groups=23, p<0.0001. Inter-group comparisons showed a significaant difference for both 
surgery and PTA over amputation and conservative therapy. Other inter-group comparisons were non-significant including PTA vs. 
Surgery. Standard error <10% at all time points except for amputation group, >10% from 1 month. 
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and reflects an elderly populat ion with advanced 
atherosclerosis. Failure to revascularise the limb, for 
whatever eason, was associated with a particularly 
high mortality, approaching 50%. Lep~intalo and 
Matzke report a similar experience from Finland with 
a 12-month survival of only 46% for unreconstructed 
CLI) ° 
The policy to attempt PTA whenever possible en- 
abled 46% of the patients in this study to be re- 
vascularised by this modal ity compared to a national 
average of 22%. 1 Furthermore, the limb salvage rates 
for PTA compare very favourably with surgery. There 
have been two randomised trials of PTA versus surgery 
for chronic leg ischaemia principally dealing with 
claudicants rather than CLI. 11'12 As in the present study 
these trials showed comparable limb salvage for PTA 
and surgery. In a retrospective comparison of PTA and 
surgery for severe limb ischaemia Blair and colleagues 
reported an unusual ly high PTA failure rate at 1- 
month of 59% and not surprisingly concluded that 
surgery was the more durable option. I3 The reported 
results of PTA, however, suggest hat improvements 
have been made over the last decade and such a high 
early failure rate is no longer representative. In two 
series collected uring the 1980s Currie 14 and Treiman 15 
describe a poor outcome for PTA but more recent 
series describe more favourable results, particularly 
for infrapopliteal PTA) 6-1s The true durabil ity of infra- 
popliteal PTA for limb salvage remains to be es- 
tablished since many of the reported series include 
procedures performed for claudication. 19'2° In selected 
patients, however, the results from more recent series 
appear favourable. The emerging evidence therefore 
suggests that with improved PTA in the 1990s there 
is a role for the use of this modal i ty in the treatment 
of l imb threatening ischaemia. 
In the present series approximately equal numbers 
of further vascular procedures were necessary to "sal- 
vage" failing grafts and failed PTAs during the 12 
months follow-up. In this regard a compl imentary 
role between surgery and PTA was seen to exist. 
Importantly, there was no evidence that a failed PTA 
compromised subsequent surgery though em- 
bolisation complicating PTA was prejudicial to one 
surgical procedure. A similar conclusion was made in 
both the randomised trials of PTA versus surgery. I1'12 
A study of PTA failures and complications by Samson 
and coworkers also failed to identify any detrimental 
effect of PTA on later surgery) 
In conclusion, the data from this study strongly 
supports the use of PTA as first line treatment for 
severe limb ischaemia with no major evidence that 
PTA is detrimental to later surgery if required. It has 
been suggested that longer term outcomes may be 
important in order to fully evaluate the value of PTA. 3 
However,  in the context of a 12-month survival of 75% 
and a 3-year survival of only 50--60% 9'2I'22 a long-term 
solution is not what many of these elderly frail patients 
require. This study highlights that as a minimally 
invasive procedure PTA serves the majority of patients 
very well, with a short hospital stay, 6 and 12-month 
limb salvage rates that equate with those achieved by 
surgery. 
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